Sleep Disorder Treatment Drug Market (By Drug Class: Sedative-hypnotics, Benzodiazepines, Dual orexin receptor antagonists, Melatonin receptor agonists, Antidepressants, Others; By Application: Intrinsic sleep disorders [Psychophysiological insomnia, Narcolepsy, Restless legs syndrome, Obstructive sleep apnea syndrome, Others], Extrinsic sleep disorders [Environmental sleep disorder, Food allergy insomnia, Toxin-induced sleep disorder, Others]; By Distribution Channel: Retail pharmacies, Online platforms, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

CHAPTER 1. Industry Overview of Sleep Disorders Treatment Drugs
1.1. Definition and Scope
1.1.1. Definition of Sleep Disorders Treatment Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Sleep Disorders Treatment Drugs Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Sleep Disorders Treatment Drugs Market By Drug Class
1.2.3. Sleep Disorders Treatment Drugs Market By Application
1.2.4. Sleep Disorders Treatment Drugs Market By Distribution Channel
1.2.5. Sleep Disorders Treatment Drugs Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Sleep Disorders Treatment Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Sleep Disorders Treatment Drugs Market
3.7. Value Chain Analysis
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Sleep Disorders Treatment Drugs Market By Drug Class
4.1. Introduction
4.2. Sleep Disorders Treatment Drugs Revenue By Drug Class
4.2.1. Sleep Disorders Treatment Drugs Revenue (US$ Mn) and Forecast, By Drug Class, 2016-2027
4.2.2. Sedative-hypnotics
4.2.2.1. Sedative-hypnotics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Benzodiazepines
4.2.3.1. Benzodiazepines Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Dual orexin receptor antagonists
4.2.4.1. Dual orexin receptor antagonists Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Melatonin receptor agonists
4.2.5.1. Melatonin receptor agonists Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Antidepressants
4.2.6.1. Antidepressants Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.7. Others
4.2.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 5. Sleep Disorders Treatment Drugs Market Revenue By Application
5.1. Introduction
5.2. Sleep Disorders Treatment Drugs Revenue (US$ Mn) By Application
5.2.1. Sleep Disorders Treatment Drugs Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
5.2.2. Intrinsic sleep disorders
5.2.2.1. Intrinsic sleep disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.2. Psychophysiological insomnia
5.2.2.3. Narcolepsy
5.2.2.4. Restless legs syndrome
5.2.2.5. Obstructive sleep apnea syndrome
5.2.2.6. Others
5.2.3. Extrinsic sleep disorders
5.2.3.1. Extrinsic sleep disorders Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.2. Environmental sleep disorder
5.2.3.3. Food allergy insomnia
5.2.3.4. Toxin-induced sleep disorder
5.2.3.5. Others

CHAPTER 6. Sleep Disorders Treatment Drugs Market By Distribution Channel
6.1. Introduction
6.2. Sleep Disorders Treatment Drugs Revenue (US$ Mn) By Distribution Channel
6.2.1. Sleep Disorders Treatment Drugs Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
6.2.2. Retail pharmacies
6.2.2.1. Retail pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Online platforms
6.2.3.1. Online platforms Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Others
6.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. North America Sleep Disorders Treatment Drugs Market By Country
7.1. North America Sleep Disorders Treatment Drugs Overview
7.2. U.S.
7.2.1. U.S. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
7.2.2. U.S. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.2.3. U.S. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.3. Canada
7.3.1. Canada Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
7.3.2. Canada Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.3.3. Canada Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
7.4. North America PEST Analysis

CHAPTER 8. Europe Sleep Disorders Treatment Drugs Market By Country
8.1. Europe Sleep Disorders Treatment Drugs Market Overview
8.2. U.K.
8.2.1. U.K. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.2.2. U.K. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.2.3. U.K. Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.3. Germany
8.3.1. Germany Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.3.2. Germany Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3.3. Germany Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.4. France
8.4.1. France Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.4.2. France Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4.3. France Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.5. Spain
8.5.1. Spain Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.5.2. Spain Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.5.3. Spain Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016-2027
8.6.2. Rest of Europe Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.6.3. Rest of Europe Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Sleep Disorders Treatment Drugs Market By Country
9.1. Asia Pacific Sleep Disorders Treatment Drugs Market Overview
9.2. China
9.2.1. China Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.2.2. China Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.2.3. China Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.3. Japan
9.3.1. Japan Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.3.2. Japan Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.3.3. Japan Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.4. India
9.4.1. India Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.4.2. India Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.4.3. India Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.5. Australia
9.5.1. Australia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.5.2. Australia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.5.3. Australia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.6.2. South Korea Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.6.3. South Korea Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
9.7.2. Rest of Asia-Pacific Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.7.3. Rest of Asia-Pacific Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Sleep Disorders Treatment Drugs Market By Country
10.1. Latin America Sleep Disorders Treatment Drugs Market Overview
10.2. Brazil
10.2.1. Brazil Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.2.2. Brazil Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.2.3. Brazil Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.3.2. Mexico Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3.3. Mexico Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
10.4.2. Rest of Latin America Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

CHAPTER 11. Middle East & Africa Sleep Disorders Treatment Drugs Market By Country
11.1. Middle East & Africa Sleep Disorders Treatment Drugs Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.2.2. Saudi Arabia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.2.3. Saudi Arabia Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.3. UAE
11.3.1. UAE Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.3.2. UAE Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3.3. UAE Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Drug Class, 2016 - 2027
11.4.2. Rest of Middle East & Africa Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4.3. Rest of Middle East & Africa Sleep Disorders Treatment Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027

CHAPTER 12. Player Analysis Of Sleep Disorders Treatment Drugs
12.1. Sleep Disorders Treatment Drugs Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Sleep Disorders Treatment Drugs Market

CHAPTER 13. Company Profile
13.1. GlaxoSmithKline plc
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. PSC Biotech 2019 Sleep Disorders Treatment Drugs Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Koninklijke Philips N.V.
13.3. Takeda Pharmaceutical Company Limited
13.4. Teva Pharmaceutical Industries Ltd.
13.5. Cardinal Health
13.6. Pfizer Inc
13.7. Sanofi
13.8. Merck & Co Inc
13.9. Becton Dickson and Company
13.10. Natus Medical Incorporated
13.11. Others